Hemp shows potential for treating ovarian cancer
24 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers demonstrate hemp's ability to slow cancer growth and uncover mechanism for its cancer-fighting ability...
List view / Grid view
Drug Targets
Anti-TNFα therapy may help reduce risk of developing Parkinson’s disease
23 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Mount Sinai shows the potential link between Parkinson's disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson's...
FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia
20 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The FDA has approved Crysvita, the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia, a rare, inherited form of rickets...
KL1333 receives FDA ODD for mitochondrial diseases
20 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
NeuroVive Pharmaceutical AB has been granted Orphan Drug Designation for its project KL1333 for treatment of inherited mitochondrial respiratory chain diseases...
Delivering cancer treatment on a nanodisc helps eliminate tumours
19 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Novel platform for chemo-immunotherapy eliminated colon cancer in 85 percent of treated mice...
Could statins ease deadly heart condition in rare neuromuscular disease?
19 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Penn study shows that cholesterol drug may help Friedreich's ataxia patients...
Diabetes drug may not reduce risk of death
18 April 2018 | By European Pharmaceutical Review
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings...
FDA accepts NDA for ALKS 5461 for major depressive disorder
18 April 2018 | By European Pharmaceutical Review
The FDA has accepted for review the New Drug Application for ALKS 5461, a novel, once-daily, oral investigational medicine for the adjunctive treatment of major depressive disorder ...
Nivolumab reduces size of some lung cancer tumours, relapse rate after surgery
16 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A drug given to early-stage lung cancer patients before they undergo surgery showed major tumour responses in the removed tumour...
Iron supplements may influence the development of colon cancer
16 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Two common iron compounds increase the formation of a known biomarker for cancer...
HRT trial demonstrates improved memory function in adrenal patients
11 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Better timing for cortisol replacement therapies, to more closely replicate the secretion patterns of people with normal levels of the hormone, has shown a significant improvement in patients' cognitive function...
Study examines antipsychotic medication for children with autism
10 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Children with intellectual difficulty or autism are more likely to be given antipsychotic medication from a younger age than those without intellectual disability...
Metformin may help with nicotine withdrawal
9 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A drug that has helped millions of people around the world manage their diabetes may also help people ready to kick their nicotine habits...
Benzodiazepines can help depression
9 April 2018 | By European Pharmaceutical Review
New research points to the important role that benzodiazepines may have in depression...
Larotrectinib shows promise in paediatric patients with TRK gene mutations
5 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A new cancer drug has proven safe and effective for paediatric patients with a rare tumour gene mutation...
Follow: